Author:
Singh Inderpreet,Singh Abhay
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Steensma DP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood J Am Soc Hematol. 2015;126(1):9–16.
2. Zink F, et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood J Am Soc Hematol. 2017;130(6):742–52.
3. Jaiswal S, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488–98.
4. Jaiswal S, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111–21.
5. • Bewersdorf JP, et al. From clonal hematopoiesis to myeloid leukemia and what happens in between: will improved understanding lead to new therapeutic and preventive opportunities? Blood Rev. 2019;37:100587. This review discusses the clonal hematopoiesis including definition, pathogenesis, adverse outcomes, and need of clinical follow up.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献